Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes

Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes

Abstract Background For rheumatoid arthritis (RA), the treat-to-target concept suggests attaining remission or at least low disease activity (LDA) after 12 weeks. Objectives This German, prospective, multicenter, non-interventional study aimed to determine the proportion of patients with RA who achi...

Full description

Bibliographic Details
Main Authors: Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaçi, Thilo Klopsch, Anja Plenske, Lisa K. Blindzellner, Pascal Klaus, Thomas Meng, Peter-Andreas Löschmann
Format: Article
Language:English
Published: Adis, Springer Healthcare 2022-02-01
Series:Rheumatology and Therapy
Subjects:
Etanercept
Remission
Real world
Rheumatoid arthritis
Online Access:https://doi.org/10.1007/s40744-021-00418-5

Internet

https://doi.org/10.1007/s40744-021-00418-5

Similar Items